Curaleaf (OTCMKTS:CURLF) Issues Quarterly Earnings Results

Curaleaf (OTCMKTS:CURLF) issued its quarterly earnings results on Wednesday. The company reported ($0.06) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.07) by $0.01, Zacks reports. Curaleaf had a negative return on equity of 14.61% and a negative net margin of 18.08%.

Curaleaf Trading Up 6.7%

OTCMKTS:CURLF traded up $0.18 during mid-day trading on Wednesday, reaching $2.85. 176,993 shares of the company’s stock traded hands, compared to its average volume of 808,603. Curaleaf has a 12-month low of $0.68 and a 12-month high of $3.65. The firm has a market capitalization of $1.92 billion, a price-to-earnings ratio of -8.91 and a beta of 0.71. The company has a debt-to-equity ratio of 1.00, a current ratio of 1.47 and a quick ratio of 0.70. The company has a 50 day moving average price of $2.89 and a 200-day moving average price of $1.82.

Analyst Upgrades and Downgrades

CURLF has been the subject of several research analyst reports. Canaccord Genuity Group raised Curaleaf to a “strong-buy” rating in a research note on Thursday, October 9th. Cormark raised Curaleaf from a “hold” rating to a “moderate buy” rating in a research note on Friday, August 8th. Two equities research analysts have rated the stock with a Strong Buy rating, According to MarketBeat.com, Curaleaf presently has a consensus rating of “Strong Buy”.

Curaleaf Company Profile

Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.